Abbott Laboratories (ABT) announced that the Food and Drug Administration has issued an "Emergency Use Authorization" for its molecular test that can detect a positive coronavirus diagnosis in as little as five minutes and a negative result in 13 minutes. The test runs on Abbott's point-of-care "ID Now" platform, a portable instrument that can be used in almost any health care setting. Traders have pushed up ABT this morning, so let's check out the charts and indicators for a longer time line than their test results.
More from Investing
2021 will be a big year, upside is at least twice the current valuation, and downside is limited to 10% from current levels.
There are huge problems now plaguing the industry, which was just beginning to recover from last year's oversupply issues.
Take control of your trades rather than just sitting and hoping that they work.
When a speculative frenzy involving one set of companies ends, cheaper peers usually aren't unscathed in the ensuing selloff.